• News

Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor

  • Medpage Today
  • New York, NY
  • (December 23, 2021)

Mark Lebwohl, MD, discusses his research finding that tapinarof improves plaque psoriasis in phase 3 trials.

Learn more